SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000935836-24-000214
Filing Date
2024-02-14
Accepted
2024-02-14 18:05:00
Documents
1
Group Members
OLEG NODELMAN

Document Format Files

Seq Description Document Type Size
1 neurogene13g.htm SC 13G 47642
  Complete submission text file 0000935836-24-000214.txt   49505
Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011
Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020
Neurogene Inc. (Subject) CIK: 0001404644 (see all company filings)

IRS No.: 980542593 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88050 | Film No.: 24641069
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 357 TEHAMA STREET #3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET #3 SAN FRANCISCO CA 94103 415-448-6534
EcoR1 Capital, LLC (Filed by) CIK: 0001587114 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G